AI assistant
ABBOTT LABORATORIES — Director's Dealing 2008
Feb 21, 2008
29777_dirs_2008-02-20_fdf5bfec-98a2-4eeb-9d35-20b11211df92.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2008-02-15
Reporting Person: Bohuon Olivier (Senior Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2008-02-17 | Common shares without par value | A | 4166 | $55.55 | Acquired | 50830 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2008-02-15 | Option (right to buy) | $55.56 | A | 97700 | Acquired | 2018-02-14 | common shares (97700) | Direct |
Footnotes
F1: Settlement of a performance-based restricted stock unit in shares in a transaction exempt from Section 16(b) under Rule 16b-3.
F2: The amount of securities beneficially owned also includes the 17,000 restricted stock units awarded on 2/16/07 and timely reported on Table II of a Form 4 dated 2/21/2007
F3: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 32,567 on 2/15/2009, 32,567 on 2/15/10, and 32,566 on 2/15/11.